<p>In a new episode of the pharmaphorum podcast, host Nicole Raleigh welcomes Joel Morse, CEO and co-founder of Curavit Clinical Research, and Andy Molnar, CEO of the Digital Therapeutics Alliance (DTA), for a discussion on why it is that digital therapeutics (DTx) are effective and safe, but not being prescribed.</p>

In a new episode of the pharmaphorum podcast, host Nicole Raleigh welcomes Joel Morse, CEO and co-founder of Curavit Clinical Research, and Andy Molnar, CEO of the Digital Therapeutics Alliance (DTA), for a discussion on why it is that digital therapeutics (DTx) are effective and safe, but not being prescribed.

Why digital therapeutics (DTx) are effective and safe, but not being prescribed

pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.

Share Why digital therapeutics (DTx) are effective and safe, but not being prescribed

Sign up to save your podcasts

Why digital therapeutics (DTx) are effective and safe, but not being prescribed

Why digital therapeutics (DTx) are effective and safe, but not being prescribed

More shows like pharmaphorum Podcast

Nature Podcast

The Daily

The Readout Loud

BioCentury This Week

The Mel Robbins Podcast